Zhou, F., Zhao, W., Gong, X., Ren, S., Su, C., Jiang, T., & Zhou, C. (2020). Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer. J Immunother Cancer.
Chicago ZitierstilZhou, Fei, Wencheng Zhao, Xiaomei Gong, Shengxiang Ren, Chunxia Su, Tao Jiang, und Caicun Zhou. "Immune-checkpoint Inhibitors Plus Chemotherapy Versus Chemotherapy As First-line Treatment for Patients With Extensive-stage Small Cell Lung Cancer." J Immunother Cancer 2020.
MLA ZitierstilZhou, Fei, et al. "Immune-checkpoint Inhibitors Plus Chemotherapy Versus Chemotherapy As First-line Treatment for Patients With Extensive-stage Small Cell Lung Cancer." J Immunother Cancer 2020.